PharMerica Reports First Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil prices, Treasury yields remain elevated
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Oppenheimer sees AI software winners as focus shifts to ROI
- Arm Holdings falls as CFO stock sale weighs on sentiment
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
Pharmerica (PMC) Tops Q1 EPS by 5c
May 7, 2015 8:29 AM EDTPharmerica (NYSE: PMC) reported Q1 EPS of $0.48, $0.05 better than the analyst estimate of $0.43. Revenue for the quarter came in at $511.6 million versus the consensus estimate of $500.95 million.
Pharmerica sees FY2015 EPS of $1.55-$1.65, versus the consensus of $1.62. Pharmerica sees FY2015 revenue of $1.95-2.05... More
